Sort
15,273 grants matching “antimicrobial resistance”
Novel Agents to Prevent Urinary Tract Infections
$187,312Marnie L Peterson · Hennepin Life Sciences · R43 · FY2015 · AI
Staphylococcus aureus and Pseudomonas aeruginosa interactions in wound pathogenesis
$187,293Alexander R Horswill · University Of Colorado Denver · R21 · FY2022 · AI
Molecular mechanisms for clinical dominance of P. aeruginosa ST111 isolates
$187,260Natasha Kirienko · Rice University · R21 · FY2025 · AI
Orthogonal Approaches to Understanding the Role of PASTA Kinases in beta-lactam Resistance
$187,150John-Demian Sauer · University Of Wisconsin-Madison · R21 · FY2020 · AI
Dual mechanism thiopeptide analogs for TB drug development
$187,142Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R21 · FY2018 · AI
Molecular Targets in Peptidoglycan Synthesis
$187,122Christopher Davies · Medical University Of South Carolina · R01 · FY2006 · GM
Optimization of novel inhibitors of mycolic acid synthesis as TB drug candidates.
$187,091Kyle H Rohde · University Of Central Florida · R21 · FY2025 · AI
Function of the Vibrio cholerae RND efflux systems
$187,041James Edward Bina · University Of Pittsburgh At Pittsburgh · R21 · FY2019 · AI
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
$187,000Samir Hanna · Tennessee State Department Of Health · U01 · FY2021 · FD
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
$187,000Samir Hanna · Tennessee State Department Of Health · U01 · FY2022 · FD
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
$187,000Samir Hanna · Tennessee State Department Of Health · U01 · FY2024 · FD
Antifouling Urinary Catheters with Active Surface Topographies
$187,000Dacheng Ren · Syracuse University · R21 · FY2020 · AI
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
$187,000Samir Hanna · Tennessee State Department Of Health · U01 · FY2023 · FD
Prevention of oxidative stress decreases persistence of drug tolerant M. Tubercu
$186,979Randall J Basaraba · Colorado State University · R21 · FY2010 · AI
Proteomic Analyses of Clostridium difficile Spore Germination Apparatus
$186,925David L Popham · Virginia Polytechnic Inst And St Univ · R21 · FY2010 · AI
Solving a Multidrug Resistance Puzzle: Complete Loss of Lipooligosaccharide
$186,917Joseph Michael Boll · University Of Texas Arlington · R21 · FY2020 · AI
Innate immune dysregulation in Alzheimer's disease modeled in Drosophila
$186,907Marc Tatar · Brown University · R21 · FY2021 · AG
Localization and characterization of the Clostridium difficile biofilm
$186,875Adam Driks · Loyola University Chicago · R21 · FY2012 · AI
Targeting P. aeruginosa penicillin-binding proteins for drug discovery
$186,875Christopher Davies · Medical University Of South Carolina · R21 · FY2015 · AI
Alternative Genetic Selection in Bacillus anthracis and Francisella tularensis
$186,875George C. Stewart · University Of Missouri-Columbia · R21 · FY2007 · AI
Randomized Intervention for Vesico-Ureteral Reflux (RIVUR) Trial
$186,841Ming-Hsien Wang · Johns Hopkins University · U01 · FY2012 · DK
IRAK4 and systemic lupus erythematosus
$186,825Andrei E Medvedev · University Of Connecticut Sch Of Med/Dnt · R21 · FY2013 · AI
Microbiota pancreas interactions during cancer
$186,813June Louise Round · University Of Utah · R21 · FY2022 · CA
Synthesis of natural product scaffold selectively active against dormant Mycobacterium tuberculosis
$186,625Steven Sucheck · University Of Toledo · R21 · FY2019 · AI
Nebulized Nitrite as a Novel Antimicrobial Therapy in Cystic Fibrosis
$186,624Anna Christine Zemke · University Of Pittsburgh At Pittsburgh · K23 · FY2017 · HL